Antagonism between two mechanisms of antifungal drug resistance

被引:15
作者
Anderson, James B. [1 ]
Ricker, Nicole [1 ]
Sirjusingh, Caroline [1 ]
机构
[1] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada
关键词
D O I
10.1128/EC.00048-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study tested for interaction between two independently evolved mechanisms of fluconazole resistance in Saccharomyces cerevisiae. One set of strains was from a 400-generation evolution experiment, during which the concentration of fluconazole was increased from 16 to 256 mu g/ml in four increments. At 100 generations, populations became fixed for resistance mutations in either of two transcriptional regulators, PDR1 or PDR3. At 400 generations, replicate populations became fixed for another resistance mutation in UNK1, an unmapped gene further increasing resistance. Another genotype used in this study came from a population placed initially in 128 mu g/ml of fluconazole; this environment selects for resistance through loss of function at ERG3, resulting in altered sterol metabolism. Mutant strains carrying PDR1(r) or PDR3(r) were crossed with the erg3(r) mutant strain, and the doubly mutant, haploid offspring were identified. The double-mutant strains grew less well than the parent strains at all concentrations of fluconazole tested. In genome-wide assays of gene expression, several ABC transporter genes that were overexpressed in one parent and several ERG genes that were overexpressed in the other parent were also overexpressed in the double mutants. Of the 43 genes that were consistently overexpressed in the PDR1(r) parents at generation 100, however, 31 were not consistently overexpressed in the double mutants. Of these 31 genes, 30 were also not consistently overexpressed after a further 300 generations of evolution in the PDR1(r) parent populations. The two independently evolved mechanisms of fluconazole resistance are strongly antagonistic to one another.
引用
收藏
页码:1243 / 1251
页数:9
相关论文
共 19 条
[1]   Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae [J].
Agarwal, AK ;
Rogers, PD ;
Baerson, SR ;
Jacob, MR ;
Barker, KS ;
Cleary, JD ;
Walker, LA ;
Nagle, DG ;
Clark, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :34998-35015
[2]   Evolution of antifungal-drug resistance: Mechanisms and pathogen fitness [J].
Anderson, JB .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (07) :547-556
[3]   Haploidy, diploidy and evolution of antifungal drug resistance in Saccharomyces cerevisiae [J].
Anderson, JB ;
Sirjusingh, C ;
Ricker, N .
GENETICS, 2004, 168 (04) :1915-1923
[4]  
Anderson JB, 2003, GENETICS, V163, P1287
[5]   Hsp90 potentiates the rapid evotution of new traits: Drug resistance in diverse fungi [J].
Cowen, LE ;
Lindquist, S .
SCIENCE, 2005, 309 (5744) :2185-2189
[6]   Population genomics of drug resistance in Candida albicans [J].
Cowen, LE ;
Nantel, A ;
Whiteway, MS ;
Thomas, DY ;
Tessier, DC ;
Kohn, LM ;
Anderson, JB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (14) :9284-9289
[7]   Multilocus genotypes and DNA fingerprints do not predict variation in azole resistance among clinical isolates of Candida albicans [J].
Cowen, LE ;
Sirjusingh, C ;
Summerbell, RC ;
Walmsley, S ;
Richardson, S ;
Kohn, LM ;
Anderson, JB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) :2930-2938
[8]   Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants [J].
DeRisi, J ;
van den Hazel, B ;
Marc, P ;
Balzi, E ;
Brown, P ;
Jacq, C ;
Goffeau, A .
FEBS LETTERS, 2000, 470 (02) :156-160
[9]  
Dobzhansky T, 1936, GENETICS, V21, P113
[10]  
Dobzhansky T., 1937, GENETICS ORIGIN SPEC